Fertility Testing Market Report
Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.
Note: The summary below might not have included insights on covid impact since we have large number of reports.
This report, from Stratview Research, studies the clinical diagnostics market - fertility testing over the trend period of 2014 to 2017 and forecast period of 2018 to 2025. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.
The Burning Questions This Report Will Answer:
As we approach 2019, it is quite clear that there’s a lot of money to be made in reproductive medicine—the industry is growing at a rapid pace and expected to generate $6.6 billion revenue by 2020. But all the products that are available in this segment, are they growing? Or are they making money on end user’s sentiments?
Amidst the uncertainty whether these products have result reproducibility, there’s the rising crop of egg-freezing start-ups, which have come under scrutiny by doctors who worry that the message of future-preparedness they promote is belied by the fact that the odds of having a baby with frozen eggs aren’t great.
While the market is flooded with kits and apps, what is lacking in this market is the in-depth scientific analysis. While there are lot of research studies on infertile women and their treatment, there are only limited studies on fertility in the general population. Physicians know very little about the mechanisms of fertility, and why getting pregnant is so easy for some and hard for others. This makes the success rate of these kits questionable.
Players such as TaiDoc Tech (Taiwan), Fetility Focus (UK), Valley Electronics (Germany), Geratherm Medical (Germany), Hilin Life Products (US), Fairhaven Health (US), are present in the market, the competition is less as compared to other diagnostic segments.
Our reports offer high-quality insights and are the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact book, press release, journals, investor presentation, white papers, patents, and articles have been leveraged to gather the data. About 10 detailed primary interviews with the market players across the value chain in all four regions and industry experts have been executed to obtain both the qualitative and quantitative insights.
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:
The global clinical diagnostics market (fertility testing) is segmented into the following categories:
By Testing Facility
With this detailed report, Stratview Research offers one of the following free customization options to our first-time clients:
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].